TABLE 1

Physicochemical properties, unbound fraction in variety of matrices, intrinsic metabolic clearance in rat hepatocytes of the selected 12 compounds

Physicochemical propertiesUnbound fraction in matricesIntrinsic metabolic CL
M.W.Log D7.4apKaaPappfu, liver tissuefu, KHB w 4%BSAfu, pfu, hepRat hepatocyte CLint,met
10−6 cm/sµl/min per 106 cells
Rosuvastatin481.5−2.74.31.80.150.210.0590.7719.8
Pravastatin424.5−0.84.30.620.290.690.630.85NA
Valsartan435.5−0.63.7, 4.20.140.048b0.006c0.00290.7920.4
Pitavastatin421.50.44.2, 5.2130.0190.0570.00650.5646.2
Fluvastatin411.50.54.3190.0150.0370.0150.5138.8
Cerivastatin459.60.64.2, 5.6280.0190.040.0290.5947.9
Nateglinide317.40.63.66.20.0370.0630.0150.7343.5
Atorvastatin558.61.34.35.50.0180.0660.0360.6390.8
Bosentan551.61.54.0160.0250.0570.00890.6639.4
Glyburide494.01.95.2220.0110.0140.0020.6054.5
Asunaprevir748.32.33.9, 5.61.70.000730.0590.0130.3136.2
Telmisartan514.64.03.5, 3.9, 5.0290.00380.0310.00610.4523.3
  • NA, not available. M.W.; Molecular Weight

  • a Predicted by Amgen in silico model.

  • b Data are referenced from Li et al. (2014).

  • c Data are referenced from Riccardi et al. (2019).